Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveen Bangia

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Immunological Investigations|August 19, 2006
Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes?Naveen Bangia, Soldano Ferrone
Immunology|February 22, 2005
Stoichiometric tapasin interactions in the catalysis of major histocompatibility complex class I molecule assemblyNaveen Bangia, Peter Cresswell
Annals of Laboratory Medicine|August 20, 2024
Comment on "Ionized Magnesium Correlates With Total Blood Magnesium in Pediatric Patients Following Kidney Transplant"Naveen Bangia, Dennis Begos, Bogdan Milojkovic
Traffic (Copenhagen, Denmark)|September 8, 2007
Aggregate formation by ERp57-deficient MHC class I peptide-loading complexesDavid Stepensky, Naveen Bangia, Peter Cresswell
Immunity|February 5, 2002
Disulfide bond isomerization and the assembly of MHC class I-peptide complexesTobias P Dick, Naveen Bangia, David R Peaper, et al.
Lasers in Surgery and Medicine|January 17, 2012
The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related moleculesAlan Belicha-Villanueva, Jonah Riddell, Naveen Bangia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemiaAsher A Chanan-Khan, Amy Whitworth, Naveen Bangia, et al.
Immunology|January 16, 2008
Differential contribution of TAP and tapasin to HLA class I antigen expressionAlan Belicha-Villanueva, Sarah McEvoy, Kelly Cycon, et al.
Immunogenetics|October 20, 2009
Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503Vilasack Thammavongsa, Malinda Schaefer, Tracey Filzen, et al.
Immunologic Research|October 16, 2009
What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?Alan Belicha-Villanueva, Jennifer Blickwedehl, Sarah McEvoy, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Immunological Investigations|August 19, 2006
Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes?Naveen Bangia, Soldano Ferrone
Immunology|February 22, 2005
Stoichiometric tapasin interactions in the catalysis of major histocompatibility complex class I molecule assemblyNaveen Bangia, Peter Cresswell
Annals of Laboratory Medicine|August 20, 2024
Comment on "Ionized Magnesium Correlates With Total Blood Magnesium in Pediatric Patients Following Kidney Transplant"Naveen Bangia, Dennis Begos, Bogdan Milojkovic
Traffic (Copenhagen, Denmark)|September 8, 2007
Aggregate formation by ERp57-deficient MHC class I peptide-loading complexesDavid Stepensky, Naveen Bangia, Peter Cresswell
Immunity|February 5, 2002
Disulfide bond isomerization and the assembly of MHC class I-peptide complexesTobias P Dick, Naveen Bangia, David R Peaper, et al.
Lasers in Surgery and Medicine|January 17, 2012
The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related moleculesAlan Belicha-Villanueva, Jonah Riddell, Naveen Bangia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemiaAsher A Chanan-Khan, Amy Whitworth, Naveen Bangia, et al.
Immunology|January 16, 2008
Differential contribution of TAP and tapasin to HLA class I antigen expressionAlan Belicha-Villanueva, Sarah McEvoy, Kelly Cycon, et al.
Immunogenetics|October 20, 2009
Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503Vilasack Thammavongsa, Malinda Schaefer, Tracey Filzen, et al.
Immunologic Research|October 16, 2009
What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?Alan Belicha-Villanueva, Jennifer Blickwedehl, Sarah McEvoy, et al.
Pageof 2